Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts.
Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina.
JAMA Netw Open. 2023 May 1;6(5):e2311012. doi: 10.1001/jamanetworkopen.2023.11012.
Women often experience physiological and functional changes in their health during midlife. Identifying women who have clinically important improvements in physical health and function and evaluating the factors associated with these improvements can identify intervention targets at midlife.
To identify factors associated with improvements in physical health and function among women during midlife.
DESIGN, SETTING, AND PARTICIPANTS: Participants were part of the Study of Women's Health Across the Nation (SWAN), a diverse cohort of US women early in midlife, and followed up annually for up to 21 years between 1996 and 2017. Analyses were based on visit 8 (2004-2006) through visit 15 (2015-2017). Statistical analysis was conducted from October 2021 to March 2023.
Sociodemographic indicators, health status measures, and comorbidities measured at visit 8.
The main outcome was a clinically important (≥5 points) improvement in the physical component score (PCS) of the 36-item Short-Form Health Survey between visit 8 and visit 15.
Of the 1807 women (at visit 8: mean [SD] age, 54.5 [2.7] years; 898 [50%] White participants) in SWAN who qualified for analysis, 265 (15%) experienced a clinically important improvement in PCS over a median of 11.1 years (IQR, 10.9-11.4 years). Factors associated with improvement in PCS included no financial strain (odds ratio [OR], 1.73; 95% CI, 1.18-2.52), no sleep disturbances (OR, 1.43; 95% CI, 1.05-1.96), no osteoarthritis (OR, 1.42; 95% CI, 1.01-1.99), and having a higher physical activity score (OR, 1.17; 95% CI, 1.00-1.37) as assessed at visit 8. Women who had a higher PCS at visit 8 (OR, 0.84; 95% CI, 0.83-0.86), who had a higher body mass index (OR, 0.95; 95% CI, 0.93-0.97), or who were taking more medications (OR, 0.93; 95% CI, 0.88-0.98) had lower odds of an improved PCS.
This cohort study of women in midlife suggests that approximately 15% of women experienced clinically important improvements in health and function over an 11-year period. Several potentially modifiable factors associated with improvements may inform women of variables to target for future interventions.
女性在中年期间经常经历生理和功能上的健康变化。确定在身体健康和功能方面有临床重要改善的女性,并评估与这些改善相关的因素,可以确定中年时期的干预目标。
确定与中年女性身体健康和功能改善相关的因素。
设计、地点和参与者:参与者是美国女性健康研究(SWAN)的一部分,这是一个在美国中年早期的多元化队列,在 1996 年至 2017 年期间每年进行一次随访,最多可达 21 年。分析基于第 8 次就诊(2004-2006 年)至第 15 次就诊(2015-2017 年)。统计分析于 2021 年 10 月至 2023 年 3 月进行。
第 8 次就诊时测量的社会人口统计学指标、健康状况指标和合并症。
主要结果是在第 8 次就诊和第 15 次就诊之间,36 项简短健康调查的身体成分评分(PCS)有临床意义的(≥5 分)改善。
在 SWAN 中,有 1807 名(第 8 次就诊时平均[标准差]年龄,54.5[2.7]岁;898[50%]为白人参与者)符合分析条件的女性中,有 265 名(15%)在中位时间为 11.1 年(IQR,10.9-11.4 年)的时间内经历了 PCS 的临床显著改善。与 PCS 改善相关的因素包括无财务压力(优势比[OR],1.73;95%置信区间[CI],1.18-2.52)、无睡眠障碍(OR,1.43;95% CI,1.05-1.96)、无骨关节炎(OR,1.42;95% CI,1.01-1.99)和第 8 次就诊时更高的身体活动评分(OR,1.17;95% CI,1.00-1.37)。第 8 次就诊时 PCS 更高的女性(OR,0.84;95% CI,0.83-0.86)、身体质量指数(OR,0.95;95% CI,0.93-0.97)更高或服用更多药物的女性(OR,0.93;95% CI,0.88-0.98),其 PCS 改善的可能性较低。
这项对中年女性的队列研究表明,大约 15%的女性在 11 年内经历了健康和功能的临床显著改善。与改善相关的几个潜在可改变因素可以为女性提供未来干预的目标变量。